Cara Therapeutics

Biotechnology Research • Stamford, Connecticut, United States • 21-50 Employees

Company overview

Headquarters	400 Atlantic St, Suite 500, Stamford, Connecticut 06901, US
Website	caratherapeutics.com
NAICS	541714
Founded	2004
Employees	21-50

Key Contacts at Cara Therapeutics

Jeffrey Ives

Director

Alia Jebara

Senior Medical Director

Diane Roth

Associate Director Clinical Project Management

Karen Joyce

Executive Director, Regulatory Affairs

Cara Therapeutics Email Formats

Cara Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@caratherapeutics.com), used 63.6% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@caratherapeutics.com	63.6%
{first name}{last name}	johndoe@caratherapeutics.com	36.4%

About Cara Therapeutics

Cara Therapeutics is a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company is developing an oral formulation of difelikefalin, a selective, peripherally acting, non-scheduled kappa opioid receptor agonist, for the treatment of chronic pruritus associated with notalgia paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back for which there are no FDA-approved therapies. The Company is conducting a Phase 2/3 clinical program in NP with topline results of the dose-finding portion expected in the third quarter of 2024. Cara Therapeutics also developed an IV formulation of difelikefalin, which is approved in the United States, EU, and multiple other countries for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.

Cara Therapeutics revenue & valuation

Annual revenue	$3,593,310
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,500,000
Total funding	$40,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Cara Therapeutics has 15 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Cara Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-02	16	$40,000,000

Funding Insights

$40,000,000

Total funding amount

$40,000,000

Most recent funding amount

Number of funding rounds

Cara Therapeutics Tech Stack

Discover the technologies and tools that power Cara Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

jQuery UI

JavaScript libraries

Google Maps

Maps

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

GeneratePress

WordPress themes

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

Cara Therapeutics is located in Stamford, Connecticut, US.

Cara Therapeutics was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

Cara Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Cara Therapeutics has raised a total of $40,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Cara Therapeutics

Jeffrey Ives

Director

Alia Jebara

Senior Medical Director

Diane Roth

Associate Director Clinical Project Management

Karen Joyce

Executive Director, Regulatory Affairs

4.8

40,000 users